• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

The management of the patient with acromegaly and headache: a still open clinical challenge.

作者信息

Giustina A, Gola M, Colao A, De Marinis L, Losa M, Sicolo N, Ghigo E

机构信息

Internal Medicine, University of Brescia, Brescia, Italy.

出版信息

J Endocrinol Invest. 2008 Oct;31(10):919-24. doi: 10.1007/BF03346442.

DOI:10.1007/BF03346442
PMID:19092299
Abstract
摘要

相似文献

1
The management of the patient with acromegaly and headache: a still open clinical challenge.肢端肥大症伴头痛患者的管理：一项仍未解决的临床挑战。
J Endocrinol Invest. 2008 Oct;31(10):919-24. doi: 10.1007/BF03346442.
2
French consensus on the management of acromegaly.法国肢端肥大症管理共识
Ann Endocrinol (Paris). 2009 Apr;70(2):92-106. doi: 10.1016/j.ando.2008.12.011. Epub 2009 Apr 5.
3
The analgesic effect and development of dependency to somatostatin analogue (octreotide) in headache associated with acromegaly.生长抑素类似物（奥曲肽）对肢端肥大症相关头痛的镇痛作用及依赖性的产生
Horm Metab Res. 1988 Apr;20(4):250-1. doi: 10.1055/s-2007-1010806.
4
[Medical treatment of acromegaly].[肢端肥大症的医学治疗]
Ann Endocrinol (Paris). 2005 Feb;66(1):55-8. doi: 10.1016/s0003-4266(05)81695-6.
5
Truncated somatostatin receptor 5 may modulate therapy response to somatostatin analogues--Observations in two patients with acromegaly and severe headache.截短的生长抑素受体5可能调节对生长抑素类似物的治疗反应——两名肢端肥大症和严重头痛患者的观察结果
Growth Horm IGF Res. 2015 Oct;25(5):262-7. doi: 10.1016/j.ghir.2015.07.003. Epub 2015 Jul 12.
6
Review of current and emerging treatment options in acromegaly.肢端肥大症当前及新出现的治疗选择综述
Neth J Med. 2015 Oct;73(8):362-7.
7
Acromegaly.
Curr Ther Endocrinol Metab. 1994;5:44-8.
8
First-line therapy of acromegaly: a statement of the A.L.I.C.E. (Acromegaly primary medical treatment Learning and Improvement with Continuous Medical Education) Study Group.肢端肥大症的一线治疗：A.L.I.C.E.（肢端肥大症初级医学治疗的持续医学教育学习与改进）研究小组声明
J Endocrinol Invest. 2006 Dec;29(11):1017-20. doi: 10.1007/BF03349217.
9
The treatment algorithm of acromegaly.肢端肥大症的治疗算法。
J Endocrinol Invest. 2003;26(8 Suppl):39-45.
10
[Therapeutic management of acromegaly].[肢端肥大症的治疗管理]
Med Klin (Munich). 2006 Jan 15;101(1):15-23. doi: 10.1007/s00063-006-1004-1.

引用本文的文献

1
Headache in pituitary adenomas: frequency, characteristics and outcome after treatment.垂体腺瘤中的头痛：频率、特征及治疗后的结果
Pituitary. 2025 Feb 9;28(2):31. doi: 10.1007/s11102-025-01504-5.
2
[Cephalgic syndrome in patients with acromegaly].[肢端肥大症患者的头部综合征]
Probl Endokrinol (Mosk). 2024 Nov 4;70(5):14-22. doi: 10.14341/probl13423.
3
Health-related Quality of Life in Acromegaly Patients: Results from Generic and Disease-specific Questionnaires.肢端肥大症患者的健康相关生活质量：通用问卷和疾病特异性问卷的结果

本文引用的文献

1
Chronic headache and pituitary tumors.慢性头痛与垂体肿瘤
Curr Pain Headache Rep. 2008 Jan;12(1):74-8. doi: 10.1007/s11916-008-0014-5.
2
The role of stereotactic radiotherapy in patients with growth hormone-secreting pituitary adenoma.立体定向放射治疗在生长激素分泌型垂体腺瘤患者中的作用。
J Clin Endocrinol Metab. 2008 Jul;93(7):2546-52. doi: 10.1210/jc.2008-0135. Epub 2008 Apr 15.
3
Cushing's Syndrome.库欣综合征
Indian J Endocrinol Metab. 2020 Sep-Oct;24(5):402-405. doi: 10.4103/ijem.IJEM_401_20. Epub 2020 Nov 9.
4
Effects of pegvisomant and somatostatin receptor ligands on incidence of vertebral fractures in patients with acromegaly.培维索孟和生长抑素受体配体对肢端肥大症患者椎骨骨折发生率的影响。
Pituitary. 2018 Jun;21(3):302-308. doi: 10.1007/s11102-018-0873-7.
5
Pegvisomant in acromegaly: an update.培维索孟治疗肢端肥大症：最新进展
J Endocrinol Invest. 2017 Jun;40(6):577-589. doi: 10.1007/s40618-017-0614-1. Epub 2017 Feb 7.
6
Challenges in the diagnosis and management of acromegaly: a focus on comorbidities.肢端肥大症诊断与管理中的挑战：关注合并症
Pituitary. 2016 Aug;19(4):448-57. doi: 10.1007/s11102-016-0725-2.
7
Biochemical and quality of life responses to octreotide-LAR in acromegaly.肢端肥大症患者用奥曲肽长效释放剂治疗后的生化和生活质量反应。
Pituitary. 2014 Dec;17(6):495-9. doi: 10.1007/s11102-013-0533-x.
8
Herniation of cerebellar tonsils in acromegaly: prevalence, pathogenesis and clinical impact.肢端肥大症小脑扁桃体疝出：流行率、发病机制和临床影响。
Pituitary. 2013 Mar;16(1):122-30. doi: 10.1007/s11102-012-0385-9.
Endocrinol Metab Clin North Am. 2008 Mar;37(1):135-49, ix. doi: 10.1016/j.ecl.2007.10.010.
4
Hyperprolactinemia and prolactinomas.高催乳素血症与催乳素瘤
Endocrinol Metab Clin North Am. 2008 Mar;37(1):67-99, viii. doi: 10.1016/j.ecl.2007.10.013.
5
Headache, idiopathic intracranial hypertension and slipped capital femoral epiphysis during growth hormone treatment: a safety update from the KIGS database.生长激素治疗期间的头痛、特发性颅内高压和股骨头骨骺滑脱：来自KIGS数据库的安全性更新
Horm Res. 2007;68 Suppl 5:41-7. doi: 10.1159/000110474. Epub 2007 Dec 10.
6
A retrospective analysis on biochemical parameters, cardiovascular risk and cardiomyopathy in elderly acromegalic patients.
J Endocrinol Invest. 2007 Jun;30(6):497-506. doi: 10.1007/BF03346334.
7
SOM230, a new somatostatin analogue, is highly effective in the therapy of growth hormone/prolactin-secreting pituitary adenomas.新型生长抑素类似物SOM230在治疗分泌生长激素/催乳素的垂体腺瘤方面疗效显著。
Clin Cancer Res. 2007 May 1;13(9):2738-44. doi: 10.1158/1078-0432.CCR-06-2505.
8
Apoplexy accompanying pituitary adenoma as a complication of preoperative anterior pituitary function tests.垂体腺瘤伴发中风作为术前垂体前叶功能试验的一种并发症。
Acta Neurochir (Wien). 2007 Jun;149(6):557-65; discussion 565. doi: 10.1007/s00701-007-1155-8. Epub 2007 Apr 30.
9
Patterns of diagnosis and acute and preventive treatment for migraine in the United States: results from the American Migraine Prevalence and Prevention study.美国偏头痛的诊断模式以及急性和预防性治疗：美国偏头痛患病率与预防研究的结果
Headache. 2007 Mar;47(3):355-63. doi: 10.1111/j.1526-4610.2006.00631.x.
10
MRI finding of simultaneous coexistence of growth hormone-secreting pituitary adenoma with intracranial meningioma and carotid artery aneurysms: report of a case.生长激素分泌型垂体腺瘤与颅内脑膜瘤及颈动脉动脉瘤同时并存的磁共振成像表现：一例报告
Pituitary. 2007;10(3):299-305. doi: 10.1007/s11102-007-0011-4.